|
PTPN23 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.801180E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.801030E-01 |
| Normal-vs-Stage2 |
2.872800E-01 |
| Normal-vs-Stage3 |
6.350400E-02 |
| Normal-vs-Stage4 |
6.28149999999383E-05 |
| Stage1-vs-Stage2 |
6.863000E-01 |
| Stage1-vs-Stage3 |
3.172600E-01 |
| Stage1-vs-Stage4 |
1.362110E-02 |
| Stage2-vs-Stage3 |
7.095200E-01 |
| Stage2-vs-Stage4 |
6.884400E-02 |
| Stage3-vs-Stage4 |
7.387500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.347620E-01 |
| Normal-vs-AfricanAmerican |
1.555380E-01 |
| Normal-vs-Asian |
6.617800E-01 |
| Caucasian-vs-AfricanAmerican |
7.487400E-01 |
| Caucasian-vs-Asian |
8.690600E-01 |
| AfricanAmerican-vs-Asian |
9.606600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.574300E-02 |
| Normal-vs-Female |
6.423200E-01 |
| Male-vs-Female |
2.881600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.326200E-01 |
| Normal-vs-Extreme_Weight |
2.390300E-02 |
| Normal-vs-Obese |
2.360400E-01 |
| Normal-vs-Extreme_Obese |
3.825800E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.615200E-01 |
| Normal_Weight-vs-Obese |
8.139000E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.525600E-01 |
| Extreme_Weight-vs-Obese |
3.279000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.745600E-01 |
| Obese-vs-Extreme_Obese |
9.363400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.912000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.193600E-01 |
| Normal-vs-Age(61-80Yrs) |
4.335800E-02 |
| Normal-vs-Age(81-100Yrs) |
1.757580E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.951200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.413800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.842050E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.770800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.463000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.658600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.674800E-01 |
| Normal-VS-Type2 PRCC |
1.538100E-03 |
| Normal-VS-KIRP CIMP |
3.105400E-01 |
| Normal-VS-Unclassified PRCC |
7.993600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.357500E-04 |
| Type1 PRCC-VS-KIRP CIMP |
5.244000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.463400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.883400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.592000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.869400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.203790E-02 |
| Normal-vs-N1 |
2.898100E-03 |
| Normal-vs-N2 |
8.283700E-02 |
| N0-vs-N1 |
5.308000E-01 |
| N0-vs-N2 |
7.601800E-01 |
| N1-vs-N2 |
9.913800E-01 |
|
|
